Revenue
-
Net Income
-$28.8M
▼ 26.2% YoY
EPS
$-0.30
0.0% YoY
Cash
$5.2M
▼ 53.0% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Kelly Jared Chief Executive Officer | Buy | Mar 12, 2026 | 5.0K | $0.96 | $5K | Form 4 ↗ |
Parsons James T. | Buy | Mar 11, 2026 | 10.0K | $1.03 | $10K | Form 4 ↗ |
Kelly Jared Chief Executive Officer | Buy | Feb 12, 2026 | 29.5K | $0.84 | $25K | Form 4 ↗ |
Look Kirk Chief Financial Officer | Buy | Feb 12, 2026 | 12.0K | $0.84 | $10K | Form 4 ↗ |
Pisano Wayne | Buy | Feb 12, 2026 | 30.0K | $0.84 | $25K | Form 4 ↗ |
Heineman Thomas Charles Chief Medical Officer | Buy | Feb 12, 2026 | 12.1K | $0.83 | $10K | Form 4 ↗ |
Brown Deborah Margaret | Buy | Feb 12, 2026 | 25.0K | $0.85 | $21K | Form 4 ↗ |
Hagerman Allison VP, Product Development | Buy | Feb 12, 2026 | 10.0K | $0.83 | $8K | Form 4 ↗ |
Seizinger Bernd R. | Buy | Feb 12, 2026 | 40.0K | $0.85 | $34K | Form 4 ↗ |
Andrews Patricia S | Buy | Feb 12, 2026 | 35.4K | $0.86 | $30K | Form 4 ↗ |
Kelly Jared Chief Executive Officer | Buy | Feb 11, 2026 | 5.6K | $0.84 | $5K | Form 4 ↗ |
Seizinger Bernd R. | Buy | Feb 11, 2026 | 60.0K | $0.83 | $50K | Form 4 ↗ |
Aromando Andrew Chief Business Officer | Buy | Feb 11, 2026 | 29.6K | $0.86 | $25K | Form 4 ↗ |